Home Label changed on Biogen's top MS drug to reflect patient death
 

Keywords :   


Label changed on Biogen's top MS drug to reflect patient death

2014-11-25 22:03:21| Biotech - Topix.net

Biogen's Tecfidera was the biggest locally developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.

Tags: top death changed drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
17.05House Republicans release farm bill draft
17.05House Republicans release farm bill draft
17.05Union forming stalled in US Mercedes-Benz
17.05Johnson & Johnson Acquires Atopic Dermatitis Treatment Biotech Company
17.05Register For Sustainable Cosmetics Summit
17.05Fewer crackers in Ritz boxes but price remains same
More »